Figure 7.
TAN’s potential as a candidate for treatments of neuroinflammation-mediated neurodegenerative disorders. AD: Alzheimer’s disease; PD: Parkinson’s disease; DM: Diabetes Miletus; NDDs: neurodegenerative disorders; UPR: unfolded protein response; CRE: cAMP response element; DA: dopamine; MMP: matrix metalloproteinases; AIF: apoptosis-inducing factor; IL: interleukin; iNOS: inducible nitric oxide synthase; COX: cyclooxygenase; TNF-α: tumor necrosis factor-alpha; ROS: reactive oxygen species; MDA: malondialdehyde; SOD: superoxide dismutase; HO: heme oxygenase; CAT: catalase; GPx: glutathione peroxidase; GR: glutathione reductase; NF-κB: nuclear factor-kappa B; ERK: extracellular-signal-regulated kinase; ↑: increase; ↓: decrease; ×: inhibited.
